藥物洗脫支架 (DES) 市場：管道報告（發展階段、細分市場、地區/國家、監管途徑、主要參與者）

Drug Eluting Stents (DES) Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

出版日期: 2023年12月11日 | 出版商:

GlobalData | 英文 152 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

藥物洗脫支架（DES）可局部釋放藥物，並且可以塗上聚合物材料。隨著時間的推移，支架會釋放抗增殖和免疫抑制藥物，從而在動脈中留下金屬支架。

本報告調查了藥物洗脫支架 (DES) 市場，提供產品概述、在研產品趨勢、各個開發階段產品的比較分析、正在進行的臨床試驗資訊以及參與公司的資訊。我們提供最近趨勢的資訊等

Abbott Vascular Inc
Adcomp Technologies Inc.
Advanced Bifurcation Systems Inc
Aeon Bioscience
B. Braun Melsungen AG
Biosensors International Group Ltd
Biotronik AG
Biotronik SE &Co KG
Boston Scientific Corp
Cardionovum GmbH
Cardiorev Pte Ltd
Columbia University
Concept Medical Inc
Cordis Corp
DISA Vascular（Pty）Ltd
Elixir Medical Corp
Endomimetics LLC
Envision Scientific Pvt Ltd
I.B.S. S.p.A.
InspireMD Inc
JW Medical Systems Ltd
Kaneka Corp
MangoGen Pharma Inc
Medinol Ltd
Medlogics Device Corp
Medtronic Plc
MicroPort Scientific Corp
MIV Therapeutics Inc
Northwestern University
NuVascular Technologies Inc
Relisys Medical Devices Ltd
REVA Medical Inc
Shandong Rientech Medical Tech Co Ltd
Shanghai BIOMAGIC Medical Device Co Ltd
Shanghai MicroPort Medical Group Co Ltd
Sino Medical Sciences Technology Inc
Stentys SA
Svelte Medical Systems Inc
Terumo Corp
Terumo Interventional Systems
TissueGen Inc
Translumina Therapeutics LLP
University of Strathclyde
VasoTech

第 6 章藥物洗脫支架 (DES) - 最新進展

第七章附錄

調查方法
關於環球數據
聯絡我們
免責聲明

簡介目錄圖表

Abstract

GlobalData's Medical Devices sector report, "Drug Eluting Stents (DES) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Drug Eluting Stents (DES) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The stent releases an antiproliferative or immunosuppressive drug over time, leaving behind the metallic stent in the artery.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Drug Eluting Stents (DES) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Drug Eluting Stents (DES) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Drug Eluting Stents (DES) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Drug Eluting Stents (DES) Overview

3 Products under Development

3.1 Drug Eluting Stents (DES) - Pipeline Products by Stage of Development
3.2 Drug Eluting Stents (DES) - Pipeline Products by Territory
3.3 Drug Eluting Stents (DES) - Pipeline Products by Regulatory Path
3.4 Drug Eluting Stents (DES) - Pipeline Products by Estimated Approval Date
3.5 Drug Eluting Stents (DES) - Ongoing Clinical Trials

4 Drug Eluting Stents (DES) - Pipeline Products under Development by Companies

4.1 Drug Eluting Stents (DES) Companies - Pipeline Products by Stage of Development
4.2 Drug Eluting Stents (DES) - Pipeline Products by Stage of Development

5 Drug Eluting Stents (DES) Companies and Product Overview

5.1 Abbott Vascular Inc Company Overview
- 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adcomp Technologies Inc. Company Overview
- 5.2.1 Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advanced Bifurcation Systems Inc Company Overview
- 5.3.1 Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Aeon Bioscience Company Overview
- 5.4.1 Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview
5.5 B. Braun Melsungen AG Company Overview
- 5.5.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
5.6 Biosensors International Group Ltd Company Overview
- 5.6.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.7 Biotronik AG Company Overview
- 5.7.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
5.8 Biotronik SE & Co KG Company Overview
- 5.8.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
5.9 Boston Scientific Corp Company Overview
- 5.9.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cardionovum GmbH Company Overview
- 5.10.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.11 Cardiorev Pte Ltd (Inactive) Company Overview
- 5.11.1 Cardiorev Pte Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.12 Columbia University Company Overview
- 5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.13 Concept Medical Inc Company Overview
- 5.13.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Cordis Corp Company Overview
- 5.14.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.15 DISA Vascular (Pty) Ltd Company Overview
- 5.15.1 DISA Vascular (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 Elixir Medical Corp Company Overview
- 5.16.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.17 Endomimetics LLC Company Overview
- 5.17.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.18 Envision Scientific Pvt Ltd Company Overview
- 5.18.1 Envision Scientific Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.19 I.B.S. S.p.A. Company Overview
- 5.19.1 I.B.S. S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
5.20 InspireMD Inc Company Overview
- 5.20.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 JW Medical Systems Ltd Company Overview
- 5.21.1 JW Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.22 Kaneka Corp Company Overview
- 5.22.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 MangoGen Pharma Inc Company Overview
- 5.23.1 MangoGen Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Medinol Ltd Company Overview
- 5.24.1 Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Medlogics Device Corp (Inactive) Company Overview
- 5.25.1 Medlogics Device Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.26 Medtronic Plc Company Overview
- 5.26.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.27 MicroPort Scientific Corp Company Overview
- 5.27.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.28 MIV Therapeutics Inc Company Overview
- 5.28.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Northwestern University Company Overview
- 5.29.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.30 NuVascular Technologies Inc Company Overview
- 5.30.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Relisys Medical Devices Ltd Company Overview
- 5.31.1 Relisys Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.32 REVA Medical Inc Company Overview
- 5.32.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Shandong Rientech Medical Tech Co Ltd Company Overview
- 5.33.1 Shandong Rientech Medical Tech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Shanghai BIOMAGIC Medical Device Co Ltd Company Overview
- 5.34.1 Shanghai BIOMAGIC Medical Device Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 Shanghai MicroPort Medical Group Co Ltd Company Overview
- 5.35.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.36 Sino Medical Sciences Technology Inc Company Overview
- 5.36.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 Stentys SA Company Overview
- 5.37.1 Stentys SA Pipeline Products & Ongoing Clinical Trials Overview
5.38 Svelte Medical Systems Inc Company Overview
- 5.38.1 Svelte Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 Terumo Corp Company Overview
- 5.39.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.40 Terumo Interventional Systems Company Overview
- 5.40.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
5.41 TissueGen Inc Company Overview
- 5.41.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.42 Translumina Therapeutics LLP Company Overview
- 5.42.1 Translumina Therapeutics LLP Pipeline Products & Ongoing Clinical Trials Overview
5.43 University of Strathclyde Company Overview
- 5.43.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
5.44 VasoTech Inc. Company Overview
- 5.44.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview